Ocular Manifestation of Non-Parenchymal Neuro-Behçet Syndrome

References
1 Behçet H. Über rezidivierende, aphthose durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 1937; 105: 1152-1157
2 Kokturk A. Clinical and pathological manifestations with differential diagnosis in Behçetʼs Disease. Patholog Res Int 2012; 2012: 690390
3 Kural-Seyahi E, Fresko I, Seyahi N et al. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003; 82: 60-76
4 Siva A, Saip S. The spectrum of nervous system involvement in Behçetʼs syndrome and its differential diagnosis. J Neurol 2009; 256: 513-529
5 Krist D, Schönherr U, Wenkel H. [Adamantiadis-Behçet syndrome: fluorescein angiography and choroid ischemia]. Klin Monbl Augenheilkd 2000; 216: 45-50
6 Keino H, Okada AA, Watanabe T et al. Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behçetʼs disease on infliximab therapy. Br J Ophthalmol 2011; 95: 1245-1250
7 Hatemi G, Silman A, Bang D et al. EULAR Expert Committee. EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 2008; 67: 1656-1662
8 Fresko I, Yazici H. Treatment strategies for Behçetʼs disease. Expert Opin Pharmacother 2008; 9: 3211-3219
9 Calamia KT, Schirmer M, Melikoglu M. Major vessel involvement in Behçetʼs disease: an update. Curr Opin Rheumatol 2011; 23: 24-31
10 Okada AA, Goto H, Ohno S, Mochizuki M. Multicenter study of infliximab for refractory uveoretinitis in Behçet disease. Arch Ophthalmol 2012; 130: 592-598